{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:59:08Z","timestamp":1790272748793,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T00:00:00Z","timestamp":1500508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.virol.2017.07.010","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T14:54:30Z","timestamp":1500908070000},"page":"185-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Longitudinal sequencing of HIV-1 infected patients with low-level viremia for years while on ART shows no indications for genetic evolution of the virus"],"prefix":"10.1016","volume":"510","author":[{"given":"Leen","family":"Vancoillie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hebberecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenny","family":"Dauwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Demecheleer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Dinakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dries","family":"Vaneechoutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Mortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Verhofstede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2017.07.010_bib1","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1128\/JVI.00284-11","article-title":"Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells","volume":"85","author":"Anderson","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.07.010_bib2","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1128\/JVI.00591-06","article-title":"Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells","volume":"80","author":"Bailey","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.07.010_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.tim.2016.01.006","article-title":"HIV-1 reservoirs during suppressive therapy","volume":"24","author":"Barton","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.virol.2017.07.010_bib4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nm.2111","article-title":"HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects","volume":"16","author":"Buzon","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2017.07.010_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.cell.2015.01.020","article-title":"HIV-1 integration landscape during latent and active infection","volume":"160","author":"Cohn","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.virol.2017.07.010_bib6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nmeth.2109","article-title":"jModelTest 2: more models, new heuristics and parallel computing","volume":"9","author":"Darriba","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.virol.2017.07.010_bib7","unstructured":"E-Biothon platform. \u3008https:\/\/www.e-biothon.fr\u3009. (Accessed 4 October 2016)."},{"key":"10.1016\/j.virol.2017.07.010_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2105-5-113","article-title":"MUSCLE: a multiple sequence alignment method with reduced time and space complexity","volume":"5","author":"Edgar","year":"2004","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.virol.2017.07.010_bib9","doi-asserted-by":"crossref","first-page":"e1002506","DOI":"10.1371\/journal.ppat.1002506","article-title":"Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection","volume":"8","author":"Evering","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2017.07.010_bib10","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1128\/JVI.77.10.5721-5730.2003","article-title":"Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy","volume":"77","author":"Frenkel","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.07.010_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/QAI.0b013e31823fd1f2","article-title":"No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy","volume":"59","author":"Gandhi","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.virol.2017.07.010_bib12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/10635150390235520","article-title":"A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood","volume":"52","author":"Guindon","year":"2003","journal-title":"Syst. Biol."},{"key":"10.1016\/j.virol.2017.07.010_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/sysbio\/syq010","article-title":"New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0","volume":"59","author":"Guindon","year":"2010","journal-title":"Syst. Biol."},{"key":"10.1016\/j.virol.2017.07.010_bib14","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1128\/JVI.73.11.9404-9412.1999","article-title":"Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy","volume":"73","author":"Gunthard","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.07.010_bib15","unstructured":"Hall T.. BioEdit. \u3008http:\/\/www.mbio.ncsu.edu\/bioedit\/bioedit\u3009. (Accessed 30 March 2017)."},{"key":"10.1016\/j.virol.2017.07.010_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/COH.0b013e32835f9788","article-title":"Immune activation and HIV persistence: considerations for novel therapeutic interventions","volume":"8","author":"Hatano","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.virol.2017.07.010_bib17","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/infdis\/jit453","article-title":"Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial","volume":"208","author":"Hatano","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2017.07.010_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/sysbio\/42.2.182","article-title":"An empirical-test of bootstrapping as a method for assessing confidence in phylogenetic analysis","volume":"42","author":"Hillis","year":"1993","journal-title":"Syst. Biol."},{"key":"10.1016\/j.virol.2017.07.010_bib19","first-page":"E4987","article-title":"The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time","volume":"110","author":"Josefsson","year":"2013","journal-title":"Proc. Natl. Acad. Sci. UAS"},{"key":"10.1016\/j.virol.2017.07.010_bib20","unstructured":"Katusiime M.G., van Zyl G.U., Wiegand A., Halvas E.K., Boltz V.F., Laughton B., Engelbrecht S., Cotton M., Mellors J.W., Kearney M.F., 2017. No evidence of ongoing HIV replication after 7 years on ART. In: Proceedings of the Conference on Retroviruses and Opportunistic Infections (CROI). Seattle. Abstract 120."},{"key":"10.1016\/j.virol.2017.07.010_bib21","doi-asserted-by":"crossref","first-page":"e1004010","DOI":"10.1371\/journal.ppat.1004010","article-title":"Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy","volume":"10","author":"Kearney","year":"2014","journal-title":"Plos Pathog."},{"key":"10.1016\/j.virol.2017.07.010_bib22","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/JVI.02139-15","article-title":"Origin of rebound plasma HIV includes cells with identical proviruses that are transcriptionally active before stopping of antiretroviral therapy","volume":"90","author":"Kearney","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.07.010_bib23","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1086\/382488","article-title":"Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads","volume":"189","author":"Kieffer","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2017.07.010_bib24","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1073\/pnas.1600097113","article-title":"Reservoir expansion by T-cell proliferation may be another barrier to curing HIV infection","volume":"113","author":"Kim","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2017.07.010_bib25","doi-asserted-by":"crossref","first-page":"e1005689","DOI":"10.1371\/journal.ppat.1005689","article-title":"Evaluating clonal expansion of HIV-infected cells: optimization of PCR strategies to predict clonality","volume":"12","author":"Laskey","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2017.07.010_bib26","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nbt1371","article-title":"Bioinformatics prediction of HIV coreceptor usage","volume":"25","author":"Lengauer","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2017.07.010_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature16933","article-title":"Persistent HIV-1 replication maintains the tissue reservoir during therapy","volume":"530","author":"Lorenzo-Redondo","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.virol.2017.07.010_bib28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.1254194","article-title":"HIV latency. specific HIV integration sites are linked to clonal expansion and persistence of infected cells","volume":"345","author":"Maldarelli","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.virol.2017.07.010_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/COH.0000000000000287","article-title":"Persistent HIV-1 replication during antiretroviral therapy","volume":"11","author":"Martinez-Picado","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.virol.2017.07.010_bib30","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1086\/650749","article-title":"Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy","volume":"50","author":"McMahon","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2017.07.010_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/aid.2006.0089","article-title":"Investigating signs of recent evolution in the pool of proviral HIV type 1 DNA during years of successful HAART","volume":"23","author":"Mens","year":"2007","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.virol.2017.07.010_bib32","doi-asserted-by":"crossref","first-page":"e80259","DOI":"10.1371\/journal.pone.0080259","article-title":"Frequency and predictors of HIV-1 co-receptor switch in treatment naive patients","volume":"8","author":"Mortier","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.virol.2017.07.010_bib33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4049\/jimmunol.1600343","article-title":"The latent reservoir for HIV-1: how immunologic memory and clonal expansion contribute to HIV-1 persistence","volume":"197","author":"Murray","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2017.07.010_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/aid.2006.0175","article-title":"Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy","volume":"23","author":"Persaud","year":"2007","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.virol.2017.07.010_bib35","unstructured":"Rambaut A.. TreeStat. \u3008http:\/\/tree.bio.ed.ac.uk\/software\/treestat\u3009. (Accessed 10 October 2016)."},{"key":"10.1016\/j.virol.2017.07.010_bib36","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1089\/aid.1997.13.737","article-title":"Quantitation of target molecules from polymerase chain reaction-based limiting dilution assays","volume":"13","author":"Rodrigo","year":"1997","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.virol.2017.07.010_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaci.2008.05.033","article-title":"Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection","volume":"122","author":"Shen","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.virol.2017.07.010_bib38","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1073\/pnas.1522675113","article-title":"Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo","volume":"113","author":"Simonetti","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2017.07.010_bib39","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/molbev\/mst197","article-title":"MEGA6: molecular evolutionary genetics analysis version 6.0","volume":"30","author":"Tamura","year":"2013","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.virol.2017.07.010_bib40","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1128\/JVI.79.15.9625-9634.2005","article-title":"Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus","volume":"79","author":"Tobin","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.07.010_bib41","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3851\/IMP2966","article-title":"Drug resistance is rarely the cause or consequence of long-term persistent low-level viraemia in HIV-1-infected patients on ART","volume":"20","author":"Vancoillie","year":"2015","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virol.2017.07.010_bib42","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1473-3099(10)70319-4","article-title":"European guidelines on the clinical management of HIV-1 tropism testing","volume":"11","author":"Vandekerckhove","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virol.2017.07.010_bib43","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.1256304","article-title":"HIV latency. proliferation of cells with HIV integrated into cancer genes contributes to persistent infection","volume":"345","author":"Wagner","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.virol.2017.07.010_bib44","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJM199905273402101","article-title":"Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy","volume":"340","author":"Zhang","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2017.07.010_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/QAI.0000000000000286","article-title":"Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy","volume":"67","author":"Zheng","year":"2014","journal-title":"J. Acquir. Immune Defic. Syndr."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682217302210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682217302210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:43:21Z","timestamp":1758588201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682217302210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":45,"alternative-id":["S0042682217302210"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2017.07.010","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal sequencing of HIV-1 infected patients with low-level viremia for years while on ART shows no indications for genetic evolution of the virus","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2017.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}